Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#CancerAwareness

Home » #CancerAwareness
Professor Jiang Zefei: Advances in the Treatment of Triple-Negative Breast Cancer

Professor Jiang Zefei: Advances in the Treatment of Triple-Negative Breast Cancer

Posted by By Mourabit Halima 2024.01.14
Editor's Note: Triple-negative breast cancer (TNBC) refers to a subtype of breast cancer where the tumor cells lack expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth…
Read More
🔬 Deciphering the Future of RCC Treatment: Prof. Manuela Schmidinger on LITESPARK Studies and HIF-2α Inhibitors

🔬 Deciphering the Future of RCC Treatment: Prof. Manuela Schmidinger on LITESPARK Studies and HIF-2α Inhibitors

Posted by By Mourabit Halima 2023.12.20
At the recent European Society for Medical Oncology (ESMO) conference, a critical spotlight was on the groundbreaking results of the LITESPARK-003 and LITESPARK-005 studies. Understanding the implications of these studies…
Read More
Recent Posts
  • EAU26 Afternoon Tea Dialogue | Prof. Jianming Guo’s Team: Disease-Specific AI Large Model Enables Precise Preoperative Assessment of Renal Cancer
  • Voice of China at ASCO-GU | Prof. Haige Chen and Prof. Ruiyun Zhang: Renji Hospital’s Urothelial Carcinoma Team Showcases Multiple Studies on the International Stage, Advancing Bladder-Preserving Therapy and Liquid Biopsy
  • EAU26 Afternoon Tea Dialogue | Prof. Jianming Guo’s Team: Hormone Therapy Combined with Cytoreductive Surgery Offers a New Strategy for Oligometastatic Prostate Cancer
  • World Kidney Day 2026 | Prof. Lei Liu: Challenges and Strategies in Preventing and Managing Infections After Kidney Transplantation
  • ASCO-GU Expert Insights | Prof. Darren Poon Interprets the BRCAAway Study: Median OS Reaches 68 Months with First-Line PARP Inhibitor Therapy in mCRPC
Recent Comments
    Archives
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top